Switch to:
Also traded in: Brazil, Chile, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.08
CVS's Cash-to-Debt is ranked lower than
92% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. CVS: 0.08 )
Ranked among companies with meaningful Cash-to-Debt only.
CVS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.14 Max: N/A
Current: 0.08
Equity-to-Asset 0.37
CVS's Equity-to-Asset is ranked higher than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. CVS: 0.37 )
Ranked among companies with meaningful Equity-to-Asset only.
CVS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.37  Med: 0.51 Max: 0.67
Current: 0.37
0.37
0.67
Interest Coverage 9.50
CVS's Interest Coverage is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.62 vs. CVS: 9.50 )
Ranked among companies with meaningful Interest Coverage only.
CVS' s Interest Coverage Range Over the Past 10 Years
Min: 9.5  Med: 11.43 Max: 15.55
Current: 9.5
9.5
15.55
Piotroski F-Score: 5
Altman Z-Score: 3.69
Beneish M-Score: -2.79
WACC vs ROIC
4.80%
10.14%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 5.57
CVS's Operating Margin % is ranked higher than
64% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.19 vs. CVS: 5.57 )
Ranked among companies with meaningful Operating Margin % only.
CVS' s Operating Margin % Range Over the Past 10 Years
Min: 5.57  Med: 6.3 Max: 6.91
Current: 5.57
5.57
6.91
Net Margin % 2.86
CVS's Net Margin % is ranked lower than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.19 vs. CVS: 2.86 )
Ranked among companies with meaningful Net Margin % only.
CVS' s Net Margin % Range Over the Past 10 Years
Min: 2.86  Med: 3.44 Max: 3.76
Current: 2.86
2.86
3.76
ROE % 14.42
CVS's ROE % is ranked higher than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.42 vs. CVS: 14.42 )
Ranked among companies with meaningful ROE % only.
CVS' s ROE % Range Over the Past 10 Years
Min: 9.14  Med: 11.33 Max: 14.42
Current: 14.42
9.14
14.42
ROA % 5.49
CVS's ROA % is ranked higher than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.26 vs. CVS: 5.49 )
Ranked among companies with meaningful ROA % only.
CVS' s ROA % Range Over the Past 10 Years
Min: 5.46  Med: 5.97 Max: 7
Current: 5.49
5.46
7
ROC (Joel Greenblatt) % 69.72
CVS's ROC (Joel Greenblatt) % is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 89.82 vs. CVS: 69.72 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CVS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 41.72  Med: 49.64 Max: 69.72
Current: 69.72
41.72
69.72
3-Year Revenue Growth Rate 16.70
CVS's 3-Year Revenue Growth Rate is ranked higher than
81% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CVS: 16.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CVS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -13.3  Med: 12.1 Max: 16.7
Current: 16.7
-13.3
16.7
3-Year EBITDA Growth Rate 11.80
CVS's 3-Year EBITDA Growth Rate is ranked higher than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.80 vs. CVS: 11.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CVS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -29.4  Med: 10.8 Max: 43.7
Current: 11.8
-29.4
43.7
3-Year EPS without NRI Growth Rate 9.40
CVS's 3-Year EPS without NRI Growth Rate is ranked higher than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. CVS: 9.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CVS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -48.3  Med: 14.6 Max: 112.8
Current: 9.4
-48.3
112.8
GuruFocus has detected 1 Warning Sign with CVS Health Corp $CVS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CVS's 30-Y Financials

Financials (Next Earnings Date: 2017-08-08)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 621399    SIC: 8099
Compare:NYSE:ANTM, NYSE:AET, NYSE:CI, NAS:ESRX, NYSE:HUM, NYSE:CNC, NYSE:WCG, NYSE:MOH, OTCPK:QULRY, NAS:MGLN, NYSE:UAM, NAS:HIIQ, OTCPK:OPRX, OTCPK:WCUI, NAS:CNXR, NYSE:UNH » details
Traded in other countries:CVSH34.Brazil, CVS.Chile, CVS.Germany, CVS.Mexico,
Headquarter Location:USA
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

CVS Health combines one of the largest retail pharmacy chains in the United States with one of the largest pharmacy benefit managers. The company processes approximately 1.3 billion prescriptions per year and operates more than 10,000 retail pharmacies across the U.S.

Guru Investment Theses on CVS Health Corp

Weitz Funds Comments on CVS Health - Jan 26, 2017

CVS Health (NYSE:CVS) operates a nationwide network of nearly 10,000 retail pharmacies, the nation’s second largest pharmacy benefits manager (PBM) in Caremark, and sizeable specialty and long-term care pharmacy platforms. This is the fund’s second go around with CVS, having last owned it back in 2013. CVS’ stock has been under pressure for most of the last 18 months after peaking during the summer of 2015. After nearly five years of consistent market share gains, the Caremark PBM suffered several client losses over the course of 2016. In addition, CVS also announced that its retail pharmacies would no longer be part of several important networks in 2017. These lost volumes will likely result in no earnings per share growth this year. These near-term negatives drove the stock down to a price that we found attractive. While management will need to navigate several risks over the course of the next couple of years, we believe CVS’ stock price provides an attractive valuation in the mid-$70s.



  • From Weitz Investment Management's Value Fund 4th quarter 2016 commentary.


Check out Wallace Weitz latest stock trades

Mario Gabelli Comments on CVS Health Corp - Nov 02, 2016

CVS Health Corp. (NYSE:CVS) (2.3%) (CVS – $88.99 – NYSE) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The stock declined in the quarter due to the significant political scrutiny around drug pricing. Efforts to regulate and control drug pricing could have an indirect impact on CVS’s revenues and earnings. However, we believe the company is a low cost provider who already works aggressively to improve health through the dispensing of low cost generic drugs, coordination of care, and efforts to improve adherence by patients.



From Mario Gabelli (Trades, Portfolio)'s Equity Income Fund 3rd quarter 2016 commentary.

Check out Mario Gabelli latest stock trades

Mario Gabelli Comments on CVS Health Corp - Feb 05, 2016

CVS Health Corp. (2.4%) (CVS – $97.77 – NYSE)(NYSE:CVS) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The company’s recent acquisitions of institutional pharmacy Omnicare and the pharmacies inside Target stores should add $0.15 to earnings in 2016 and further CVS’s dominance across the pharmacy channel. Same store sales should improve in 2016 now that the company has annualized its decision to stop selling tobacco, and that decision has helped them win over $11 billion in net new business for its pharmacy benefits management (PBM) division.

From Mario Gabelli (Trades, Portfolio)'s GAMCO Equity Income Fund fourth quarter 2015 commentary.

Check out Mario Gabelli latest stock trades

Top Ranked Articles about CVS Health Corp

Points of Light Recognizes CVS Health As One Of The 50 Most Community-Minded Companies In The United States
CVS Health Joins Drug Store News and Mack Elevation in Convening Health Innovation Summit
Cigna and CVS Health Launch Cigna Health Works, A New Model for Customer-Enabled Design for Affordable, Convenient Access to Pharmacy and Health Care
CVS Pharmacy Now Using Time Delay Safes in Ohio for Controlled Substances to Combat Opioid Epidemic, Reduce Robbery Incidents
CVS Pharmacy Opens First Retail Location in Colorado
David Dreman Buys JPMorgan, Kroger, Reynolds Guru's largest 1st-quarter purchases
David Dreman (Trades, Portfolio) is the founder and chairman of Dreman Value Management LLC and also serves as the firm's chief investment officer. During the first quarter the guru bought shares in the following stocks. Read more...
Attorney General Brnovich, Rep. Carter Join CVS Health to Announce Availability of Naloxone at All CVS Pharmacy Locations in Arizona
NWQ Managers Sells Pfizer, Viacom, Edison The firm's largest 1st-quarter sales
NWQ Managers (Trades, Portfolio) is a value-oriented money management firm with several funds products and more than $54 billion under management. During the first quarter the guru sold shares in the following stocks: Read more...
CVS Pharmacy Launches Long Live Skin Campaign to Increase Awareness Around Sun Safety and Skin Health
CVS Health To Present At The UBS Global Healthcare Conference

Ratios

vs
industry
vs
history
PE Ratio 16.12
CVS's PE Ratio is ranked higher than
73% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.08 vs. CVS: 16.12 )
Ranked among companies with meaningful PE Ratio only.
CVS' s PE Ratio Range Over the Past 10 Years
Min: 10.58  Med: 17.45 Max: 27.17
Current: 16.12
10.58
27.17
Forward PE Ratio 13.33
CVS's Forward PE Ratio is ranked higher than
82% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.64 vs. CVS: 13.33 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 16.09
CVS's PE Ratio without NRI is ranked higher than
76% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.08 vs. CVS: 16.09 )
Ranked among companies with meaningful PE Ratio without NRI only.
CVS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 10.62  Med: 17.48 Max: 27.17
Current: 16.09
10.62
27.17
Price-to-Owner-Earnings 9.57
CVS's Price-to-Owner-Earnings is ranked higher than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.70 vs. CVS: 9.57 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CVS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.07  Med: 20.2 Max: 60.62
Current: 9.57
9.07
60.62
PB Ratio 2.36
CVS's PB Ratio is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.70 vs. CVS: 2.36 )
Ranked among companies with meaningful PB Ratio only.
CVS' s PB Ratio Range Over the Past 10 Years
Min: 1.01  Med: 1.79 Max: 3.37
Current: 2.36
1.01
3.37
PS Ratio 0.46
CVS's PS Ratio is ranked higher than
75% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. CVS: 0.46 )
Ranked among companies with meaningful PS Ratio only.
CVS' s PS Ratio Range Over the Past 10 Years
Min: 0.4  Med: 0.59 Max: 0.88
Current: 0.46
0.4
0.88
Price-to-Free-Cash-Flow 9.01
CVS's Price-to-Free-Cash-Flow is ranked higher than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.32 vs. CVS: 9.01 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CVS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.91  Med: 20.52 Max: 105.34
Current: 9.01
8.91
105.34
Price-to-Operating-Cash-Flow 7.34
CVS's Price-to-Operating-Cash-Flow is ranked higher than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.84 vs. CVS: 7.34 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CVS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.72  Med: 12.59 Max: 19.92
Current: 7.34
6.72
19.92
EV-to-EBIT 11.13
CVS's EV-to-EBIT is ranked higher than
60% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.21 vs. CVS: 11.13 )
Ranked among companies with meaningful EV-to-EBIT only.
CVS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.6  Med: 11.3 Max: 20.4
Current: 11.13
7.6
20.4
EV-to-EBITDA 8.79
CVS's EV-to-EBITDA is ranked higher than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.10 vs. CVS: 8.79 )
Ranked among companies with meaningful EV-to-EBITDA only.
CVS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 9.05 Max: 16
Current: 8.79
6.2
16
PEG Ratio 1.14
CVS's PEG Ratio is ranked higher than
71% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.81 vs. CVS: 1.14 )
Ranked among companies with meaningful PEG Ratio only.
CVS' s PEG Ratio Range Over the Past 10 Years
Min: 0.57  Med: 1.29 Max: 2.34
Current: 1.14
0.57
2.34
Shiller PE Ratio 22.24
CVS's Shiller PE Ratio is ranked higher than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.59 vs. CVS: 22.24 )
Ranked among companies with meaningful Shiller PE Ratio only.
CVS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.09  Med: 25.73 Max: 39.05
Current: 22.24
17.09
39.05
Current Ratio 1.08
CVS's Current Ratio is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. CVS: 1.08 )
Ranked among companies with meaningful Current Ratio only.
CVS' s Current Ratio Range Over the Past 10 Years
Min: 1.05  Med: 1.53 Max: 2.64
Current: 1.08
1.05
2.64
Quick Ratio 0.56
CVS's Quick Ratio is ranked lower than
81% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. CVS: 0.56 )
Ranked among companies with meaningful Quick Ratio only.
CVS' s Quick Ratio Range Over the Past 10 Years
Min: 0.2  Med: 0.51 Max: 0.93
Current: 0.56
0.2
0.93
Days Inventory 34.77
CVS's Days Inventory is ranked lower than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.05 vs. CVS: 34.77 )
Ranked among companies with meaningful Days Inventory only.
CVS' s Days Inventory Range Over the Past 10 Years
Min: 34.77  Med: 41.44 Max: 50.81
Current: 34.77
34.77
50.81
Days Sales Outstanding 24.73
CVS's Days Sales Outstanding is ranked higher than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.28 vs. CVS: 24.73 )
Ranked among companies with meaningful Days Sales Outstanding only.
CVS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.77  Med: 22.19 Max: 28.31
Current: 24.73
18.77
28.31
Days Payable 17.85
CVS's Days Payable is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 44.46 vs. CVS: 17.85 )
Ranked among companies with meaningful Days Payable only.
CVS' s Days Payable Range Over the Past 10 Years
Min: 16.69  Med: 19.59 Max: 21.78
Current: 17.85
16.69
21.78

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.38
CVS's Dividend Yield % is ranked higher than
77% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.47 vs. CVS: 2.38 )
Ranked among companies with meaningful Dividend Yield % only.
CVS' s Dividend Yield % Range Over the Past 10 Years
Min: 0.42  Med: 1.16 Max: 2.38
Current: 2.38
0.42
2.38
Dividend Payout Ratio 0.37
CVS's Dividend Payout Ratio is ranked lower than
67% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.25 vs. CVS: 0.37 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CVS' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.2 Max: 0.37
Current: 0.37
0.11
0.37
3-Year Dividend Growth Rate 23.60
CVS's 3-Year Dividend Growth Rate is ranked higher than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. CVS: 23.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CVS' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -33.8  Med: 8 Max: 37
Current: 23.6
-33.8
37
Forward Dividend Yield % 2.56
CVS's Forward Dividend Yield % is ranked higher than
81% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.70 vs. CVS: 2.56 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 8.15
CVS's 5-Year Yield-on-Cost % is ranked higher than
81% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.55 vs. CVS: 8.15 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CVS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.44  Med: 3.97 Max: 8.15
Current: 8.15
1.44
8.15
3-Year Average Share Buyback Ratio 3.50
CVS's 3-Year Average Share Buyback Ratio is ranked higher than
72% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. CVS: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CVS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -22.9  Med: -0.4 Max: 4.7
Current: 3.5
-22.9
4.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.72
CVS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.04 vs. CVS: 0.72 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CVS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.67  Med: 1.39 Max: 26.44
Current: 0.72
0.67
26.44
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.00
CVS's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
80% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.57 vs. CVS: 1.00 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.79
CVS's Price-to-Median-PS-Value is ranked higher than
77% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. CVS: 0.79 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CVS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.43  Med: 0.92 Max: 2.54
Current: 0.79
0.43
2.54
Price-to-Peter-Lynch-Fair-Value 1.23
CVS's Price-to-Peter-Lynch-Fair-Value is ranked higher than
67% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. CVS: 1.23 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CVS' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.64  Med: 1.48 Max: 6.55
Current: 1.23
0.64
6.55
Earnings Yield (Greenblatt) % 8.98
CVS's Earnings Yield (Greenblatt) % is ranked higher than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.71 vs. CVS: 8.98 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CVS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.9  Med: 8.8 Max: 13.2
Current: 8.98
4.9
13.2
Forward Rate of Return (Yacktman) % 19.83
CVS's Forward Rate of Return (Yacktman) % is ranked higher than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.88 vs. CVS: 19.83 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CVS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 11.8  Med: 18.1 Max: 24.2
Current: 19.83
11.8
24.2

More Statistics

Revenue (TTM) (Mil) $178,825.00
EPS (TTM) $ 4.79
Beta0.58
Short Percentage of Float2.50%
52-Week Range $69.30 - 98.66
Shares Outstanding (Mil)1,018.80

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 184,556 195,741 205,979
EPS ($) 5.75 6.31 6.92
EPS without NRI ($) 5.75 6.31 6.92
EPS Growth Rate
(Future 3Y To 5Y Estimate)
14.69%
Dividends per Share ($) 1.92 2.11 3.05
» More Articles for CVS

Headlines

Articles On GuruFocus.com
MainStay Suites in Sidney, Montana, Wins Hotel of the Year Award Jun 22 2017 
Weibo Announces Receipt of a SAPPRFT Notice Jun 22 2017 
AT&T Hosts Cybersecurity Training Camps for Teens Jun 22 2017 
WEIBO (WB) ALERT: J&W Commences an Investigation of Weibo Corporation; Investors Encouraged to Conta Jun 22 2017 
FTSE Russell to Ring The Nasdaq Stock Market Closing Bell Jun 22 2017 
Statement of Clarification with Regards to Tiger Reef, Inc. Letter of Intent Jun 22 2017 
Proteon Therapeutics Announces $22.0 Million Private Placement Jun 22 2017 
Intercept’s Ocaliva® (obeticholic acid) Receives 2017 Galien Chemical Synthesis Drug Award i Jun 22 2017 
Onvia Announces Nationwide Tour to Help Businesses Grow Their Public Sector Sales Jun 22 2017 
Dr Pepper Snapple Group Names Lain Hancock CEO Of Bai Brands Jun 22 2017 

More From Other Websites
3 Dividend Growth Stocks to Buy in Retail Jun 22 2017
BioDelivery Inks New Contract with CVS/Caremark, Shares Up Jun 22 2017
Uber wants Facebook’s Sheryl Sandberg to take the wheel after CEO Travis Kalanick bails out Jun 21 2017
Facebook's Sandberg in Running for Top Job at Uber Jun 21 2017
S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 Jun 21 2017
Points of Light Recognizes CVS Health As One Of The 50 Most Community-Minded Companies In The United... Jun 21 2017
CVS Health Corp. – Value Analysis (NYSE:CVS) : June 20, 2017 Jun 20 2017
Eosinophilic Esophagitis: Major Market Opportunity for Dupixent? Jun 20 2017
Here’s who could lead Uber out of its scandals Jun 20 2017
Is Amazon serious about getting into pharmacy? This analyst isn’t so sure Jun 20 2017
CVS Health Set to Take a Turn for the Worse Jun 20 2017
If Walgreens Can't Close Rite Aid Deal, Amazon Has An Opening Jun 20 2017
Rite Aid Stock Just Had Its Best Gain In 20 Months As Walgreens Deadline Nears Jun 19 2017
Could Amazon Get Into the Pharmacy Game Next? Jun 19 2017
CVS & Walgreens: Are Pharmacies in Amazon's Crosshairs? Jun 19 2017
CVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : June 19, 2017 Jun 19 2017
Today's Research Reports on Stocks to Watch: CVS Health and Walgreens Boots Alliance Jun 19 2017
Why Whole Foods Market's Gain Is CVS Health's and Walgreens' Loss Today Jun 16 2017
Amazon destroys $28.5B of competitors' stock wealth after Whole Foods buy Jun 16 2017
3 Stocks With Better Dividends Than CVS Health Corporation Jun 15 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}